Pediatrix Medical Group (NYSE:MD) Downgraded by StockNews.com

StockNews.com cut shares of Pediatrix Medical Group (NYSE:MD) from a hold rating to a sell rating in a report issued on Monday morning.

Several other analysts have also recently issued reports on MD. Jefferies Financial Group cut their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a hold rating for the company in a research report on Wednesday, March 6th. Truist Financial reissued a hold rating and set a $10.00 price target on shares of Pediatrix Medical Group in a research note on Wednesday, May 15th. Finally, Deutsche Bank Aktiengesellschaft raised Pediatrix Medical Group from a sell rating to a hold rating and set a $8.00 price target for the company in a research note on Friday, June 7th. One analyst has rated the stock with a sell rating and five have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of Hold and a consensus price target of $9.10.

Pediatrix Medical Group Stock Performance

Shares of MD opened at $7.70 on Monday. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.81. The business has a 50-day simple moving average of $8.00 and a two-hundred day simple moving average of $8.86. The stock has a market cap of $647.96 million, a price-to-earnings ratio of -9.06, a PEG ratio of 1.52 and a beta of 1.54. Pediatrix Medical Group has a 52 week low of $6.70 and a 52 week high of $15.02.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.15 by $0.02. The business had revenue of $495.10 million during the quarter, compared to analysts’ expectations of $496.25 million. Pediatrix Medical Group had a positive return on equity of 10.31% and a negative net margin of 3.53%. On average, analysts expect that Pediatrix Medical Group will post 1.13 EPS for the current year.

Institutional Investors Weigh In On Pediatrix Medical Group

Hedge funds and other institutional investors have recently modified their holdings of the business. Boston Partners purchased a new stake in shares of Pediatrix Medical Group in the fourth quarter worth approximately $12,452,000. Clark Estates Inc. NY purchased a new stake in shares of Pediatrix Medical Group in the fourth quarter worth approximately $3,302,000. Pacer Advisors Inc. raised its holdings in shares of Pediatrix Medical Group by 126.9% in the fourth quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock worth $30,092,000 after buying an additional 1,809,828 shares during the period. Connable Office Inc. purchased a new stake in shares of Pediatrix Medical Group in the fourth quarter worth approximately $217,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Pediatrix Medical Group by 10.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,634,065 shares of the company’s stock worth $15,197,000 after buying an additional 148,600 shares during the period. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.